| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/04/2003 | WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 09/04/2003 | WO2002053699A3 Chondrocyte-specific and non-specific elements in the fgfr-3 promoter region |
| 09/04/2003 | WO2002052020A3 Regulation of human carboxypeptidase a |
| 09/04/2003 | WO2002049501A3 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 09/04/2003 | WO2002046220A3 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 09/04/2003 | WO2002045708A3 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 09/04/2003 | WO2002044331A3 Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer |
| 09/04/2003 | WO2002038767A3 G protein-coupled receptor protein and nucleic acid molecules and uses therefor |
| 09/04/2003 | WO2002029103A3 Gene expression profiles in liver cancer |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2002008456A3 Method for identifying metastatic tumor cells |
| 09/04/2003 | WO2001092299A3 Adenovirus particles with mutagenized fiber proteins |
| 09/04/2003 | WO2001086002A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 09/04/2003 | WO2001081622A3 Diagnosis of diseases associated with dna repair |
| 09/04/2003 | WO2001076451A3 Diagnosis of diseases associated with metabolism |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences |
| 09/04/2003 | US20030167478 Epsin protein detected in injuries; controlling cell differentiation, cell proliferation |
| 09/04/2003 | US20030167476 Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand |
| 09/04/2003 | US20030166917 Purification by chromatography, ion exchanging, analyzing |
| 09/04/2003 | US20030166911 Hybrid nucleic acids; genetic engineering |
| 09/04/2003 | US20030166907 Mammalian neuro-growth factor like protein |
| 09/04/2003 | US20030166906 Hybrid polynucleotides; modulate immunology response |
| 09/04/2003 | US20030166902 Hybrid; process control; genetic engineering |
| 09/04/2003 | US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents |
| 09/04/2003 | US20030166897 Diagnosis, therapy cancer; transgenic animal |
| 09/04/2003 | US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders |
| 09/04/2003 | US20030166890 Antibiotic resistance genes; transgenic animals |
| 09/04/2003 | US20030166883 Genetic engineering; drug screening |
| 09/04/2003 | US20030166875 Fibroblast growth factor homologous factor-2 and methods of use |
| 09/04/2003 | US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration |
| 09/04/2003 | US20030166853 Mucin peptide with immunoenhancing properties |
| 09/04/2003 | US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound |
| 09/04/2003 | US20030166850 Containing an isolated human evectin polypeptide binding domain |
| 09/04/2003 | US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 09/04/2003 | US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds |
| 09/04/2003 | US20030166604 Modulating transcription of genes in vascular cells |
| 09/04/2003 | US20030166603 Using a p53- expressing viral vector as anticarcinogenic agents |
| 09/04/2003 | US20030166601 Drug delivery of the nucleic acid into a target tissue or cell, comprising a core complex contains a nucleic acid and complex forming agents, fusion with cell membranes with nuclear uptake; polymeric outer shell |
| 09/04/2003 | US20030166599 Uses of tgap7 for the modulation of leucocyte activation |
| 09/04/2003 | US20030166593 Non-viral vesicle vector for cardiac specific gene delivery |
| 09/04/2003 | US20030166591 Testosterone-repressed prostate message-2 (TRPM-2); gene expression inhibition; increased antitumor activity |
| 09/04/2003 | US20030166588 Splice-region antisense composition and method |
| 09/04/2003 | US20030166587 Compounds and methods for modulating activation of NF-kB |
| 09/04/2003 | US20030166549 Targeting peptides |
| 09/04/2003 | US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions. |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166536 Expression product of DNA encoding human or hybrid human/ mammalian factor VIII, said DNA comprising DNA encoding a modified A2 domain, the DNA having one or more nucleotide substitutions resulting in a coding change at one or more of |
| 09/04/2003 | US20030166533 Genes for male accessory gland proteins in Drosophila melanogaster |
| 09/04/2003 | US20030166526 Novel gene (designated 158P1H4) and its encoded protein are described. While 158P1H4 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1H4 |
| 09/04/2003 | US20030166504 Therapeutic compositions and methods for treating viral infection |
| 09/04/2003 | US20030166287 Gene therapy, drug delivery a virus-like particle for binding to a human transport protein; antitumor agents |
| 09/04/2003 | US20030166286 Chimeric adenoviral fiber protein and methods of using same |
| 09/04/2003 | US20030166285 Methods and compositions for genetically modifying primate bone marrow cells |
| 09/04/2003 | US20030166284 Encoding hepatitis B virus surface antigen, treating hepatic diseases; inverted terminal repeats has the native D-sequences modified, some nucleotides are deleted or replaced; genetic engineering |
| 09/04/2003 | US20030166281 Genetic transcription, cells comprising regulatory sequence, a reporter gene to express a signal peptide, protein biosynthesis; reducing neutrophils, expression of human growth hormone |
| 09/04/2003 | US20030166280 Drug deliverying a complex wherein the zeta potential is not positive, expressing nucleic acids in cells |
| 09/04/2003 | US20030166272 Contacting a committed cell with an antibody to retrodifferentiate; therapeutic treatment of an immunological disorder or disease; stem cells |
| 09/04/2003 | US20030166271 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy |
| 09/04/2003 | US20030166252 Paramyxovirus-derived RNP |
| 09/04/2003 | US20030166251 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 09/04/2003 | US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 09/04/2003 | US20030166238 Recombinant toxin fragments |
| 09/04/2003 | US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK) |
| 09/04/2003 | US20030166198 Antibodies to mitogenic oxygenases |
| 09/04/2003 | US20030166164 IL-17 like molecules and uses thereof |
| 09/04/2003 | US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2003 | US20030166141 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/04/2003 | US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all |
| 09/04/2003 | US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases |
| 09/04/2003 | US20030166065 Novel integrin ligand ITGL-TSP |
| 09/04/2003 | US20030166045 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 09/04/2003 | US20030166026 Comprises expression vector which codes reporter molecule for detection and modulation of tumor phenotypes in mammary glands |
| 09/04/2003 | US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy |
| 09/04/2003 | US20030166021 Box-dependent Myc-interacting protein (BIN1) compositions and uses therefor |
| 09/04/2003 | US20030166004 Comprises synthetic or genetically engineered peptide or polypeptide which comprises endothelial cell binding peptides (ECBP) for inhibit angiogenesis and related diseases such as cancer, arthritis and vision defects |
| 09/04/2003 | US20030165975 Novel human lipase proteins, nucleic acids encoding them, and uses of both of these |
| 09/04/2003 | US20030165973 Identifying modulators of peroxisome proliferator activated receptors gamma coactivator-1 (PGC-1) for preventing or treating cancer, obesity, cardiovascular, diabetic and chronic obstructive pulmonary diseases |
| 09/04/2003 | US20030165930 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof |
| 09/04/2003 | US20030165924 Comprises nucleotide sequences transcribed in cells which accumulate multiple intracellular lipid droplets for diagnosing atherosclerosis |
| 09/04/2003 | US20030165907 Human glycine transporter type 2 |
| 09/04/2003 | US20030165892 Unigene unidirectional antisense library |
| 09/04/2003 | US20030165878 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 09/04/2003 | US20030165875 Novel receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof |
| 09/04/2003 | US20030165874 Nucleotide sequences probes for diagnosing and treating seizure disorders; restriction fragment length polymorphisms |
| 09/04/2003 | US20030165831 Comprise nucleotide sequences for diagnosing and treating gynecological tumors; antitumor/anticarcinogenic agents |
| 09/04/2003 | US20030165820 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 09/04/2003 | US20030165818 Detecting modulators of serine protease/dipeptidyl peptidase activity for treating viral/muscular/bone/nervous system disorders |
| 09/04/2003 | US20030165809 MARKs as modifiers of the p53 pathway and methods of use |
| 09/04/2003 | US20030165807 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 09/04/2003 | US20030165538 Vaccines, biocatalyst; supplying to respiratory system, mucous membrane; modulate immunology response; fusion protein with spore overcoatings |
| 09/04/2003 | US20030165535 Gag protein genes; reduced sensitivity |
| 09/04/2003 | US20030165521 Influenza vaccine |
| 09/04/2003 | US20030165520 Attenuated forms of bovine viral diarrhea virus |
| 09/04/2003 | US20030165506 Novel alpha-catenin expressed in heart and testis |
| 09/04/2003 | US20030165497 RRP sequences and knockout mice and uses thereof |
| 09/04/2003 | US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering |
| 09/04/2003 | US20030165490 22196, a novel human aminopeptidase |
| 09/04/2003 | US20030165488 Polypeptides; culture product |